Ronen Marmorstein, Ph.D.

George W. Raiziss Professor
Department: Biochemistry and Biophysics
Graduate Group Affiliations
Contact information
BRB II/III, Room 454
421 Curie Blvd.
Philadelphia, PA 19104-6161
421 Curie Blvd.
Philadelphia, PA 19104-6161
Office: (215) 898-7740
Fax: (215) 746-5511
Fax: (215) 746-5511
Email:
marmor@upenn.edu
marmor@upenn.edu
Publications
Education:
B.S. (Chemistry and Genetics)
University of California, Davis, 1984.
Ph.D. (Chemistry)
University of Chicago, 1989.
M.S. (Physical Chemistry )
University of Chicago, 1989.
Cert. (Mentoring Facilitator For Faculty)
Perelman School of Medicine, 2022.
Permanent linkB.S. (Chemistry and Genetics)
University of California, Davis, 1984.
Ph.D. (Chemistry)
University of Chicago, 1989.
M.S. (Physical Chemistry )
University of Chicago, 1989.
Cert. (Mentoring Facilitator For Faculty)
Perelman School of Medicine, 2022.
Description of Research Expertise
Research InterestsBiochemical, biophysical, X-ray crystallographic and cryo-EM techniques. Age-associated diseases such as cancer, and metabolic and neurodegenerative disorders.
Key words: Epigenetics, chromatin regulation, metabolism, protein acetylation, kinases, oncoproteins, X-ray Crystallography, Cryo-EM, enzymology, structure, biophysics, inhibitor development.
Description of Research
The Marmorstein laboratory studies the molecular mechanisms of (1) protein post- and co-translational protein acetylation and acetyl-CoA metabolism, (2) gene expression and epigenetic regulation, and (3) MAPK signaling. The laboratory uses a broad range of biochemical, biophysical and structural research tools (X-ray crystallography and cryo-EM) to determine macromolecular structure and mechanism of action, with a particular focus on macromolecules that are aberrantly regulated in age-associated diseases such as cancer, and metabolic and neurodegenerative disorders. The laboratory also uses high-throughput small molecule screening and structure-based design strategies to develop protein-specific small-molecule probes to interrogate protein function and for preclinical studies. Specific areas of focus are described below:
Epigenetic regulation
DNA within the eukaryotic nucleus is compacted into chromatin containing histone proteins and its appropriate regulation orchestrates gene expression programs that allow cells with identical genetic information to exhibit different phenotypes. These epigenetic changes are mediated by proteins that recognize DNA and native and modified histones; assemble chromatin called histone chaperones; modify the histones through the addition or removal of functional chemical groups such as acetyl, methyl or phosphate; and non-coding RNA molecules. The laboratory is particularly interested in understanding the molecular mechanism of DNA binding proteins, histone chaperones and histone post-translational modifications enzymes. The laboratory is also studying the molecular links between metabolism and epigenetic regulation.
Protein acetylation and acetyl-CoA metabolism
Thousands of proteins, including histones, are acetylated throughout the cell to regulate diverse biological processes, thus placing acetyltransferases on the same playing field as kinases. Indeed, emerging biochemical and structural data further supports mechanistic and biological links between the two enzyme families. Because of this correlation, the laboratory is studying the broad family of protein acetyltransferases that acetylate lysine side chains (KATs), protein N-termini (NATs) and other substrates. The laboratory is particularly interested in how these enzymes are regulated by protein cofactors to modulate substrate activity and specificity, and how protein acetyltransferases might be targeted by small molecule compounds to create molecular probes and therapeutic compounds. The laboratory is also studying the molecular mechanism of proteins involved in the metabolism of the protein acetyltransferase cofactor, acetyl-CoA, and are developing protein inhibitors in this space for treatment of cancer and metabolic disorders.
MAPK signaling
The laboratory is studying the structure and function of protein kinases and their associated proteins that are aberrantly regulated in melanoma and other cancers. The laboratory is also exploiting this understanding to develop novel small molecule inhibitors as molecular probes and as lead molecules for development to treat various cancers.
Rotation Projects
Rotation Students with an interest in incorporating the techniques of molecular biology, biochemistry, X-ray crystallography, cryo-EM, enzymology and inhibitor development to study areas of interest to the laboratory are encouraged to inquire by e-mail to Dr. Marmorstein to discuss specific rotation projects.
Lab personnel:
Postdoctoral Fellows:
Stephano Iglesias
Samar Mohapatra
Xin Xu
Elaine Zhou
Graduate Students:
Meng Li
Kollin Schultz
Yolanda Simpson
Julianna Supplee
Boyu (Eric) Yin
Karen Zhang
Athena Zhang
Research Specialists:
Taining Li
Zhiyuan Zhang
Lab Manager:
Lauren Gardner
Undergraduate Students:
Oscar Mendez
Elizabeth Wang
Selected Publications
Riscal R, Gardner SM, Coffey NJ, Carens M, Mesaros C, Xu JP, DavisL, Demczyszyn S, Vogt A, Olia A, Finan JM, Jason G, Blair IA, Keith B, Marmorstein R, Skuli N, Simon MC: Activation of the bile acid pathway promotes tumorigenesis in clear cell renal cell carcinoma. Cancer Research 84: 1570-1582, 2024.Hao X, Zhao B, Towers M, Liao L, Monteiro EL, Xu X, Freeman C, Peng H, Tang H-Y, Havas A, Kossenkov AV, Berger SL, Adams PD, Speicher DW, Schultz D, Marmorstein R, Zaret KS, Zhang R: TXNRD1 drives innate immune response in senescent cells with implications in age-assocaited inflammation. Nature Aging 4: 185-197, 2024.
Supplee JG, Affronti HC, Duan R, Brooks RC, Stine ZE, Nguyen PTT, Pinheiro LV, Noji MC, Drummond JM, Huang K, Schultz K, Dang CV, Marmorstein R, Wellen KE: ACLY alternative splicing correlates with cancer phenotypes. J Biol Chem 2024.
Kim HJ, Szurgot MR, van Eeuwen T, Ricketts MD, Basnet P, Zhang AL, Vogt A, Sharmin S, Kaplan CD, Garcia BA, Marmorstein R, Murakami K: Structure of the Hir histone chaperone complex. Mol Cell 84: 2601-2617, Jul 2024.
Vogt A, Szurgot M, Gardner L, Schultz DC, Marmorstein R: HIRA complex deposition of histone H3.3 is driven by histone tetramerization and histone-DNA binding. J Biol Chem 2024.
Gardner SM, Vogt A, Penning TM, Marmorstein R: Substrate specificity and kinetic mechanism of 3β-hydroxy-Δ(5)-C(27)-steroid oxidoreductase. J Biol Chem 2024.
Schultz K, Costa-Pinheiro P, Gardner L, Pinheiro LV, Ramirez-Solis J, Gardner S, Wellen KE, Marmorstein R: Snalshots of acyl carrier protein shuttling in human fatty acid synthase. Nature 2025 Notes: In press.